Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates

Company Performance - Nuwellis, Inc. reported a quarterly loss of $0.69 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.45, representing an earnings surprise of -53.33% [1] - The company posted revenues of $1.9 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 23.84%, and showing a slight increase from $1.86 million in the same quarter last year [2] - Over the last four quarters, Nuwellis has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance - Nuwellis shares have declined approximately 10.8% since the beginning of the year, contrasting with the S&P 500's decline of -0.6% [3] - The current Zacks Rank for Nuwellis is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.36 on revenues of $2.65 million, and for the current fiscal year, it is -$1.39 on revenues of $10.87 million [7] - The outlook for the Medical - Instruments industry, where Nuwellis operates, is currently in the top 31% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]